PPA
DCPH

Parametric Portfolio Associates’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Parametric Portfolio Associates’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.28M Buy
245,582
+49,289
+25% +$419K ﹤0.01% 2353
2021
Q4 		$1.92M Buy
196,293
+117,807
+150% +$2.22M ﹤0.01% 2460
2021
Q3 		$2.67M Buy
78,486
+29,427
+60% +$939K ﹤0.01% 2257
2021
Q2 		$1.8M Buy
49,059
+8,625
+21% +$334K ﹤0.01% 2497
2021
Q1 		$1.81M Buy
40,434
+3,444
+9% +$160K ﹤0.01% 2847
2020
Q4 		$2.11M Buy
36,990
+13,097
+55% +$776K ﹤0.01% 2620
2020
Q3 		$1.23M Sell
23,893
-5,136
-18% -$252K ﹤0.01% 2791
2020
Q2 		$1.73M Sell
29,029
-2,308
-7% -$123K ﹤0.01% 2588
2020
Q1 		$1.29M Sell
31,337
-7,064
-18% -$392K ﹤0.01% 2647
2019
Q4 		$2.39M Buy
38,401
+11,928
+45% +$567K ﹤0.01% 2582
2019
Q3 		$898K Buy
26,473
+237
+0.9% +$7.02K ﹤0.01% 3081
2019
Q2 		$592K Buy
26,236
+2,922
+13% +$68.4K ﹤0.01% 3293
2019
Q1 		$541K Buy
23,314
+1,995
+9% +$52.2K ﹤0.01% 3297
2018
Q4 		$447K Sell
21,319
-22,060
-51% -$542K ﹤0.01% 3362
2018
Q3 		$1.68M Buy
43,379
+9,209
+27% +$340K ﹤0.01% 2828
2018
Q2 		$1.34M Buy
+34,170
New +$1.01M ﹤0.01% 2902
2018
Q1 		– Sell
-17,894
Closed -$406K – 3971
2017
Q4 		$406K Buy
+17,894
New +$350K ﹤0.01% 3437

Other funds holding DCPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Parametric Portfolio Associates's DCPH Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 25% in Q1 2022, buying an estimated $419K and bringing the position to 245,582 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Parametric Portfolio Associates first reported a position in DCPH in Q4 2017 and has held it in 17 quarters since. The position peaked at $2.67M in Q3 2021. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

  • Parametric Portfolio Associates held 245,582 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $2.28M as of Q1 2022.
  • Parametric Portfolio Associates bought 49,289 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $419K.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2353 holding.
  • Parametric Portfolio Associates first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and has held it in 17 quarters since.
  • Parametric Portfolio Associates's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.67M in Q3 2021.
  • 123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.